These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9108812)

  • 1. Clozapine and associated diabetes mellitus.
    Popli AP; Konicki PE; Jurjus GJ; Fuller MA; Jaskiw GE
    J Clin Psychiatry; 1997 Mar; 58(3):108-11. PubMed ID: 9108812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.
    Hägg S; Joelsson L; Mjörndal T; Spigset O; Oja G; Dahlqvist R
    J Clin Psychiatry; 1998 Jun; 59(6):294-9. PubMed ID: 9671341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
    Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
    Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
    Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
    J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.
    Henderson DC
    J Clin Psychiatry; 2001; 62 Suppl 23():39-44. PubMed ID: 11603884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes mellitus after treatment with clozapine].
    Brugman NJ; Cohen D; de Vries RH
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):437-9. PubMed ID: 10719549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozaphobia: Is avoidance of clozapine in diabetes warranted?
    Sreeraj VS; Dinakaran D; Nagendrappa S; Rao NP; Kesavan M; Varambally S; Venkatasubramanian G
    Asian J Psychiatr; 2017 Aug; 28():142-145. PubMed ID: 28784368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
    Tovey E; Rampes H; Livingstone C
    J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
    Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
    J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus associated with clozapine therapy.
    Wehring H; Alexander B; Perry PJ
    Pharmacotherapy; 2000 Jul; 20(7):844-7. PubMed ID: 10907975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus.
    Grover S; Verma M; Chakrabarti S
    J Clin Psychopharmacol; 2020; 40(3):276-282. PubMed ID: 32195772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose olanzapine-induced improvement of preexisting type 2 diabetes mellitus in schizophrenic patients.
    Lerner V; Libov I; Kanevsky M
    Int J Psychiatry Med; 2003; 33(4):403-10. PubMed ID: 15152791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.
    Henderson DC; Nguyen DD; Copeland PM; Hayden DL; Borba CP; Louie PM; Freudenreich O; Evins AE; Cather C; Goff DC
    J Clin Psychiatry; 2005 Sep; 66(9):1116-21. PubMed ID: 16187768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia associated with the use of atypical antipsychotics.
    Lindenmayer JP; Nathan AM; Smith RC
    J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of New-Onset Diabetes After Long-Term Treatment With Clozapine in Comparison to Other Antipsychotics in Patients With Schizophrenia.
    Schulte PF; Bocxe JT; Doodeman HJ; van Haelst IM; Cohen D
    J Clin Psychopharmacol; 2016 Apr; 36(2):115-9. PubMed ID: 26872114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine.
    Feng S; Melkersson K
    Neuro Endocrinol Lett; 2012; 33(5):493-8. PubMed ID: 23090266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
    Sernyak MJ; Gulanski B; Rosenheck R
    J Clin Psychiatry; 2005 Nov; 66(11):1463-7. PubMed ID: 16420085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose intolerance with atypical antipsychotics.
    Hedenmalm K; Hägg S; Ståhl M; Mortimer O; Spigset O
    Drug Saf; 2002; 25(15):1107-16. PubMed ID: 12452735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.